If he squeezes enough money from the big shots to see us through at least H1 CY25, preferably all of CY25, then I don't mind the dilution.
Personally, I have no extra cash to put into this company anyway.
Any cash I get, I have a half dozen other biotechs in mind to diversify.
Ann: Notice of Extraordinary General Meeting/Proxy Form, page-41
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.951M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.0¢ | $38.54K | 3.639M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2646760 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 729690 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |